Dark zone lymphoma includes aggressive B-cell lymphomas with shared molecular features. While some respond to escalated ...

An investigational induced pluripotent stem cell-derived CAR natural killer cell therapy was well tolerated both as ...

Panelists discuss key factors in deciding between monotherapy and combination approaches for bispecific therapies in follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) as well as the ...

CMN-005 is under development for the treatment of relapsed and refractory B-cell acute lymphocytic leukemia, chronic lymphocytic leukemia (CLL) and b-cell non-Hodgkin lymphoma, follicular lymphoma ...

CMN-005 is under development for the treatment of relapsed and refractory B-cell acute lymphocytic leukemia, chronic lymphocytic leukemia (CLL) and b-cell non-Hodgkin lymphoma, follicular lymphoma ...

It shows a correlation between Tfh and activated Tfh and disease activity, and an association between activated Tph and Tfh and some B-cell markers. In addition, our study focuses on Tph in pSS.

Objectives T follicular helper ... for expansion of Tfh-Th1-like cells and potentially helpful towards development of cell-specific treatment for SLE. Tfh cells express the chemokine receptor 5 (CXCR5 ...

Panelists discuss how several studies evaluating bispecific therapies in earlier lines of therapy for diffuse large B-cell lymphoma and follicular lymphoma suggest that patients with high-risk or ...

Results: Single-cell analysis revealed distinct immune cell subtypes and indicated an increased presence of myeloid dendritic cells (mDCs ... identified by the ID finn-b-K11_PERIODON_CHRON, which ...

Their collaboration has resulted in engineered cells called ‘synthetic organizers’ that deliver instructions to stem cells, telling them to grow into specific tissues and organs.